Jobson Medical files for chapter 11 debt relief

Share this article:

Jobson Medical Information Holdings filed for chapter 11 bankruptcy in New York Thursday, the company said, part of an effort to amend and extend its credit and strengthen its balance sheet

The closely held company, which is backed by private equity firm Wicks Group, said lenders have already approved its plan and that it expects to emerge from the “pre-packaged” Chapter 11 process in about 30 to 40 days.

“This credit agreement will provide us with the flexibility needed to continue our growth,” said Jeff MacDonald, CEO of Jobson Medical Information Holdings. “JMIH is a very strong and profitable business and will continue to operate.”

In 2005 Jobson Medical Information Holdings bought medical imprint Jobson Publishing for an undisclosed sum. Titles include US Pharmacist20/20 and Review of Optometry. Shortly after, it scooped up med-ed firm DesignWrite. JMIH also controls accredited CME provider Postgraduate Institute for Medicine, as well as information services /alert Marketing and Frames Data.

According to a Bloomberg report, JMIH listed assets and debt of as much as $500 million each in its chapter 11 petition, and 16 affiliates also sought court protection.

The company is one of several B2B magazine operators that have refinanced their debt over the last year-and-a-half due to a challenging market, including Hanley Wood (2012), Summit Business Media (2011) and Penton Media (2010).

“Jobson has an excellent stable of assets, and with the economic downturn and the impact upon them, [it] just made their balance sheet untenable,” said Roland DeSilva, managing partner of media banker DeSilva+Phillips.

Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.